Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2026-05-12 @ 9:51 PM
Study NCT ID:
NCT03091933
Status:
UNKNOWN
Last Update Posted:
2017-12-06
First Post:
2017-03-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)
Sponsor:
Ciusss de L'Est de l'Île de Montréal
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CR-MIHA-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None